Author
Shiliang Li
East China Normal UniversityORCID 0000-0003-4414-237XUnclaimed ORCID profile · follow to get notified of new preprints
Additional preprints under this name without ORCID
Biology Disciplines
Click to filter author papersSignature Assays, Organisms & Methods
Click to filter · or open tagActivity by Year
2024-2026 · peak 1/yrCo-Author Collaboration Network
10 top collaborators · 35 mutual co-author linksFocal author (center)Selected co-authorORCID co-authorUnlinked name
Curved chords = mutual co-authorship3 papers
Recent·Most cited
- Cancer BiologybioRxivPreprint
Contrastive Learning-Enhanced Drug Metabolite Prediction Drives the Discovery of an Orally Bioavailable RSK4 Inhibitor for Esophageal Cancer
Huan He, Manzhan Zhang, Xiaoxiao Yang…·Shiliang Li
The paper develops ConMeter, a metabolite prediction model, and uses it to design an orally bioavailable RSK4 inhibitor with improved bioavailability and anti-tumor efficacy against esophageal cancer.
2 citations - BiochemistrybioRxivPreprint
Structural insights into sphingosine 1-phosphate receptor 4 activation
Wei Gao, Shiyi Gan, Mengting Zhang…·Honglin Li
The paper determines the cryo-EM structure of activated S1PR4, revealing mechanisms of ligand recognition and Gi coupling to aid in developing safer S1PR4 agonists.